Public information presented according to the provisions of Directive 2001/18/ECFile: b-be-02-b7-summary-notification-information-format.pdfTrial reference: Phase II study evaluating the clinical efficacy of TG4010 (MVA-MUC1-IL2) in patients with metastatic Renal Cell Carcinoma (RCC) Doc type: Information for the public
